Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berstad

Showing results (281-290 of 291) with videos related to

Pageof 30
Sort By:
BMJ (Clinical Research Ed.)|August 27, 1999
Heartburn treatment in primary care: randomised, double blind study for 8 weeksJ G Hatlebakk, A Hyggen, P H Madsen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 3, 2004
Laboratory handling of Helicobacter pylori critically influences the results of in-vitro metronidazole resistance determinationT H Henriksen, F Lerang, A Lia, et al.
Alimentary Pharmacology & Therapeutics|May 8, 1999
Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazoleS Olafsson, A Berstad, C J Bang, et al.
Scandinavian Journal of Gastroenterology|November 17, 2004
Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oilT Bjørkkjaer, L A Brunborg, G Arslan, et al.
Scandinavian Journal of Gastroenterology|March 1, 1990
Low-dose antacids versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre studyP G Farup, R Weberg, A Berstad, et al.
Scandinavian Journal of Gastroenterology|March 1, 1993
Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trialJ G Hatlebakk, A Berstad, L Carling, et al.
The American Journal of Gastroenterology|May 1, 1996
Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain)S Tefera, A Berstad, C J Bang, et al.
Hepato-Gastroenterology|September 1, 1995
Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infectionA Berstad, J G Hatlebakk, I Wilhelmsen, et al.
Alimentary Pharmacology & Therapeutics|August 5, 2003
Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meetingG N Tytgat, R C Heading, S Müller-Lissner, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 10, 1994
[10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year]A Berstad, K Berstad, J G Hatlebakk, et al.
Pageof 30

Showing results (281-290 of 291) with videos related to

Sort By:
Pageof 30
BMJ (Clinical Research Ed.)|August 27, 1999
Heartburn treatment in primary care: randomised, double blind study for 8 weeksJ G Hatlebakk, A Hyggen, P H Madsen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 3, 2004
Laboratory handling of Helicobacter pylori critically influences the results of in-vitro metronidazole resistance determinationT H Henriksen, F Lerang, A Lia, et al.
Alimentary Pharmacology & Therapeutics|May 8, 1999
Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazoleS Olafsson, A Berstad, C J Bang, et al.
Scandinavian Journal of Gastroenterology|November 17, 2004
Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oilT Bjørkkjaer, L A Brunborg, G Arslan, et al.
Scandinavian Journal of Gastroenterology|March 1, 1990
Low-dose antacids versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre studyP G Farup, R Weberg, A Berstad, et al.
Scandinavian Journal of Gastroenterology|March 1, 1993
Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trialJ G Hatlebakk, A Berstad, L Carling, et al.
The American Journal of Gastroenterology|May 1, 1996
Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain)S Tefera, A Berstad, C J Bang, et al.
Hepato-Gastroenterology|September 1, 1995
Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infectionA Berstad, J G Hatlebakk, I Wilhelmsen, et al.
Alimentary Pharmacology & Therapeutics|August 5, 2003
Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meetingG N Tytgat, R C Heading, S Müller-Lissner, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 10, 1994
[10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year]A Berstad, K Berstad, J G Hatlebakk, et al.
Pageof 30